Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Looking to Q4 2015 earnings report release...
View:
Post by visionaryfool on Jan 08, 2016 12:17pm

Looking to Q4 2015 earnings report release...

I think the stock will be around $60/share if the news is in line with what they have said. Factors to consider: (1) integration of AMCO in Q4 2015; (2) whether investor day will increase confidence in the company. Having seen the CEO on networks, I think investors day cannot come soon enough!!
Comment by visionaryfool on Jan 08, 2016 12:18pm
Forgot to ask what other people think in terms of price target after news release. I'm at $60/share
Comment by pfeghali on Jan 08, 2016 12:20pm
what happens on investor day?
Comment by visionaryfool on Jan 08, 2016 4:13pm
I'm hoping that they provide overall business update (AMCO purchase and performance, confirm debt repayment, anything in the pipeline). I think they might do investor day at the same time as their financials are released. We'll see!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities